<DOC>
	<DOCNO>NCT02481518</DOCNO>
	<brief_summary>The purpose study determine whether magnesium preloading reduce incident cisplatin induce acute kidney injury head neck cancer receive low dose cisplatin ( 40 mg/m2 weekly 7 week ) .</brief_summary>
	<brief_title>Preloading Magnesium Attenuate Cisplatin-induced Nephrotoxicity</brief_title>
	<detailed_description>Randomized controlled trial compare efficacy magnesium preloading versus normal saline prevention acute chronic nephrotoxicity cisplatin .</detailed_description>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Age &gt; 18 year Eastern Cooperative Oncology Group score 02 First Diagnosed Head neck cancer plan treatment cisplatin Serum creatinine ≤1.5 mg/dl eGFR≥60 ( ml/min/1.73 m2 ) Prior treatment cisplatin randomization Uncontrolled concurrent disease Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cisplatin nephrotoxicity</keyword>
	<keyword>Acute kidney injury</keyword>
</DOC>